Creative Planning
ONCY

Creative Planning’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Creative Planning’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-990
Closed -$1K – 4302
2014
Q2 		$1K Buy
+990
New +$1.42K ﹤0.01% 3716

Other funds holding ONCY

1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Creative Planning's ONCY Position: Q3 2014 in Review

Creative Planning sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q3 2014, closing a stake of 990 shares — an estimated $1K sold.

Creative Planning first reported a position in ONCY in Q2 2014 and held it in 1 quarter. The position peaked at $1K in Q2 2014. 30 funds tracked by Wall St. Rank hold ONCY as of Q3 2014.

  • Creative Planning reported no remaining ONCOLYTICS BIOTECH INC position as of Q3 2014 after selling out during the quarter.
  • Creative Planning sold 990 ONCOLYTICS BIOTECH INC shares in Q3 2014, an estimated $1K.
  • Creative Planning first reported a position in ONCOLYTICS BIOTECH INC in Q2 2014 and held it in 1 quarter.
  • Creative Planning's ONCOLYTICS BIOTECH INC position peaked at $1K in Q2 2014.
  • 30 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q3 2014.

Based on Creative Planning's 13F filing for Q3 2014, filed 10 Oct 2014.